UM

Browse/Search Results:  1-10 of 17 Help

Selected(0)Clear Items/Page:    Sort:
ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials Journal article
Wang G., Zheng W., Li X.-B., Wang S.-B., Cai D.-B., Yang X.-H., Ungvari G.S., Xiang Y.-T., Correll C.U.. ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials[J]. Journal of Psychiatric Research, 2018, 105, 23-32.
Authors:  Wang G.;  Zheng W.;  Li X.-B.;  Wang S.-B.;  Cai D.-B.; et al.
Favorite | TC[WOS]:66 TC[Scopus]:74 | Submit date:2018/12/18
Clozapine  Ect  Headache  Memory  Remission  Response  Schizophrenia  Treatment-resistant  
Insomnia in Adults With Chronic Hepatitis B, Liver Failure, and Cirrhosis: A Case–Control Study Journal article
Guo H.-M., Liu M., Xiang Y.-T., Zhao J., Ungvari G.S., Correll C.U., Ng C.H., Chiu H.F.K., Duan Z.-P.. Insomnia in Adults With Chronic Hepatitis B, Liver Failure, and Cirrhosis: A Case–Control Study[J]. Perspectives in Psychiatric Care, 2017, 53(1), 67-72.
Authors:  Guo H.-M.;  Liu M.;  Xiang Y.-T.;  Zhao J.;  Ungvari G.S.; et al.
Favorite | TC[WOS]:7 TC[Scopus]:9 | Submit date:2018/12/18
Chronic Hepatitis  Cirrhosis  Hbv-related Liver Failure  Insomnia  
Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials Journal article
Zheng W., Xiang Y.-T., Xiang Y.-Q., Li X.-B., Ungvari G.S., Chiu H.F.K., Correll C.U.. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials[J]. Acta Psychiatrica Scandinavica, 2016, 134(5), 385-398.
Authors:  Zheng W.;  Xiang Y.-T.;  Xiang Y.-Q.;  Li X.-B.;  Ungvari G.S.; et al.
Favorite | TC[WOS]:42 TC[Scopus]:53 | Submit date:2018/12/18
Antipsychotic  Meta-analysis  Metabolic Abnormalities  Topiramate  Weight Gain  
Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia Journal article
Hou C.-L., Xiang Y.-T., Wang Z.-L., Everall I., Tang Y., Yang C., Xu M.-Z., Correll C.U., Jia F.-J.. Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia[J]. Schizophrenia Research, 2016, 174(1-3), 71-76.
Authors:  Hou C.-L.;  Xiang Y.-T.;  Wang Z.-L.;  Everall I.;  Tang Y.; et al.
Favorite | TC[WOS]:45 TC[Scopus]:49 | Submit date:2018/12/18
Cognitive Functioning  Schizophrenia  Ultra-high Risk For Psychosis  
Smoking in male patients with schizophrenia in China: A meta-analysis Journal article
Li Y., Cao X., Zhong B.-L., Ungvari G.S., Chiu H.F.K., Lai K.C.L., Zheng W., Correll C.U., Xiang Y.-T.. Smoking in male patients with schizophrenia in China: A meta-analysis[J]. Drug and Alcohol Dependence, 2016, 162, 146-153.
Authors:  Li Y.;  Cao X.;  Zhong B.-L.;  Ungvari G.S.;  Chiu H.F.K.; et al.
Favorite | TC[WOS]:32 TC[Scopus]:35 | Submit date:2018/12/18
China  Male  Meta-analysis  Schizophrenia  Smoking  
Prevalence of aggression in hospitalized patients with schizophrenia in China: A meta-analysis Journal article
Zhou J.-S., Zhong B.-L., Xiang Y.-T., Chen Q., Cao X.-L., Correll C.U., Ungvari G.S., Chiu H.F.K., Lai K.Y.C., Wang X.-P.. Prevalence of aggression in hospitalized patients with schizophrenia in China: A meta-analysis[J]. Asia-Pacific Psychiatry, 2016, 8(1), 60-69.
Authors:  Zhou J.-S.;  Zhong B.-L.;  Xiang Y.-T.;  Chen Q.;  Cao X.-L.; et al.
Favorite | TC[WOS]:57 TC[Scopus]:66 | Submit date:2018/12/18
Aggression  Meta-analysis  Psychiatric Ward  Schizophrenia  
Self-Reported and Interviewer-Rated Oral Health in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder Journal article
Tang L.-R., Zheng W., Zhu H., Ma X., Chiu H.F.K., Correll C.U., Ungvari G.S., Xiang Y.-Q., Lai K.Y.C., Cao X.-L., Li Y., Zhong B.-L., Lok K.I., Xiang Y.-T.. Self-Reported and Interviewer-Rated Oral Health in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder[J]. Perspectives in Psychiatric Care, 2016, 52(1), 4-11.
Authors:  Tang L.-R.;  Zheng W.;  Zhu H.;  Ma X.;  Chiu H.F.K.; et al.
Favorite | TC[WOS]:15 TC[Scopus]:15 | Submit date:2018/12/18
Bipolar Disorder  Major Depression  Oral Health  Psychiatric Inpatient  Schizophrenia  
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study Journal article
Hu Y.-D., Xiang Y.-T., Fang J.-X., Zu S., Sha S., Shi H., Ungvari G.S., Correll C.U., Chiu H.F.K., Xue Y., Tian T.-F., Wu A.-S., Ma X., Wang G.. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study[J]. Psychological Medicine, 2016, 46(3), 623.
Authors:  Hu Y.-D.;  Xiang Y.-T.;  Fang J.-X.;  Zu S.;  Sha S.; et al.
Favorite | TC[WOS]:109 TC[Scopus]:117 | Submit date:2018/10/30
Escitalopram  Ketamine  Key Words Efficacy  Major Depression  Response  Tolerability  
Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012) Journal article
Li Q., Xiang Y.-T., Su Y.-A., Shu L., Yu X., Correll C.U., Ungvari G.S., Chiu H.F.K., Ma C., Wang G.-H., Bai P.-S., Li ., Sun L.-Z., Shi J.-G., Chen X.-S., Mei Q.-Y., Li K.-Q., Si T.-M., Kane J.M.. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012)[J]. Schizophrenia Research, 2015, 168(1-2), 523-529.
Authors:  Li Q.;  Xiang Y.-T.;  Su Y.-A.;  Shu L.;  Yu X.; et al.
Favorite | TC[WOS]:14 TC[Scopus]:16 | Submit date:2018/12/18
Clozapine  Prescription Patterns  Schizophrenia  
Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients? Journal article
Ma X.-R., Hou C.-L., Zang Y., Jia F.-J., Lin Y.-Q., Li Y., Chiu H.F.K., Ungvari G.S., Correll C.U., Lai K.Y.C., Zhong B.-L., Cao X.-L., Cai M.-Y., Yun J., Xiang Y.-T.. Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients?[J]. Journal of Affective Disorders, 2015, 172, 191-194.
Authors:  Ma X.-R.;  Hou C.-L.;  Zang Y.;  Jia F.-J.;  Lin Y.-Q.; et al.
Favorite | TC[WOS]:9 TC[Scopus]:11 | Submit date:2018/12/18
Depressive Symptoms  Inventory Of Depressive  Psychometric Properties  Quick  Schizophrenia  Self-report  Symptomatology